Publication Name	World Journal of Psychiatry
Manuscript ID	4432
Country	United Kingdom

Received	2013-06-29 19:24
Peer-Review Started	2013-06-29 21:02
To Make the First Decision	2013-07-05 18:33
Return for Revision	2013-07-09 14:15
Revised	2013-08-24 04:37
Second Decision	2013-09-03 14:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-09-04 07:36
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-11-06 18:59
Publish the Manuscript Online	2013-11-20 17:37

ISSN	2220-3206 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Psychiatry
Manuscript Type	Minireviews
Article Title	Acetyl Cholinesterase inhibitors in cognitive impairment in Huntington’s disease: A brief review
Manuscript Source	Invited Manuscript
All Author List	Joe John Vattakatuchery and Renjith Kurien
Funding Agency and Grant Number
Corresponding Author	Joe John Vattakatuchery, MBBS, MRCPsych, Consultant Psychiatrist, 5 Boroughs Partnership NHS Foundation Trust, Hollins Park House, Hollins Lane, Warrington WA28WA, United Kingdom. joejohn@doctors.net.uk
Key Words	Huntington’s disease; Huntington’s dementia; Cognitive deficits; Acetyl Cholinesterase inhibitors; Donepezil; Rivastigmine; Galantamine
Core Tip	The evidence for Acetyl Cholinesterase inhibitors in the treatment of cognitive decline and dementia associated with Huntington’s disease is reviewed in this article. Six articles were identified that investigated the role of Acetyl Cholinesterase inhibitors for treatment of cognitive deficits in Huntington’s disease (HD). We concluded that there is limited evidence for the use of Acetyl Cholinesterase inhibitors for cognitive impairment in HD.
Publish Date	2013-11-20 17:37
Citation	Vattakatuchery JJ, Kurien R. Acetylcholinesterase inhibitors in cognitive impairment in Huntington’s disease: A brief review. World J Psychiatr 2013; 3(3): 62-64
URL	http://www.wjgnet.com/2220-3206/full/v3/i3/62.htm
DOI	http://dx.doi.org/10.5498/wjp.v3.i3.62

Full Article (PDF)	WJP-3-62.pdf
Manuscript File	4432-Review.doc
Answering Reviewers	4432-Answering reviewers.pdf
Copyright License Agreement	4432-Copyright assignment.pdf
Peer-review Report	4432-Peer review(s).pdf
Scientific Editor Work List	4432-Scientific editor work list.doc